Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05619172
Title A Study of Nanrilkefusp Alfa (SOT101) in Combination With Cetuximab to Evaluate the Efficacy and Safety in Patients With Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors SOTIO Biotech AG
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | ESP | BEL

Additional content available in CKB BOOST